The 5th Annual Cancer BioPartnering & Investment Forum will be held on March the 28th, 2017 in New York, USA.

Andre Choulika, PhD, Chairman and Chief Executive Officer of Cellectis, to take part in this event with a Keynote Speech at 9:40 AM, titled "Gene editing coupled to cell therapy: a paradigm shift in oncology," then in the panel "Cell and Gene Therapies - Advances and Setbacks" at 2:45 PM.